Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07608458 · ClinicalTrials.gov registry record · NA
Scheduled Meditation for Improving Postoperative Outcomes in Patients Undergoing Pancreatectomy
A NA study, sponsored by City of Hope Medical Center.
- Not yet
- Registry status
- NA
- Development phase
- 70
- Enrollment target
NCT07608458: Clinical Trial NA study, sponsored by City of Hope Medical Center.
NCT07608458 is a NA study that has not yet begun recruiting, run by City of Hope Medical Center. The registered enrollment target is 70 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07608458, a NA study, has not yet begun recruiting, sponsored by City of Hope Medical Center.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
Study Summary
This clinical trial tests the feasibility and how well a scheduled meditation intervention works to improve postoperative outcomes such as pain, anxiety, insomnia, stress and mobility for patients undergoing pancreatectomy. Many patients undergoing pancreatectomy surgery report clinically important fatigue, pain, and/or reduction in quality of life. Meditation is a behavioral intervention that has been studied in a variety of medical and surgical settings, where it has been associated with reductions in pain, anxiety, blood pressure, and lack of sleep, and in some cases with decreased pain and shorter length of stay. The meditation intervention using Headspace is an easily accessible and interactive way to complete scheduled meditation. This may improve postoperative outcomes for patients undergoing pancreatectomy.
Primary Outcome
Retention will be considered feasible if ≥ 70% of enrolled participants are retained. Will be estimated along with the 95% exact binomial confidence interval.
Interventions
- OTHER Survey Administration
- BEHAVIORAL Online Mindfulness Meditation
- BEHAVIORAL Smartphone Application-based Intervention
- OTHER Actigraphy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2026-06-25 |
| Est. Completion | 2026-11-25 |
| Phase | NA |
What is known before NCT07608458 opens enrollment
NCT07608458 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 4 interventions - of which Survey Administration is the first listed.
NCT07608458 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07608458 about?
NCT07608458 is a clinical study titled "Scheduled Meditation for Improving Postoperative Outcomes in Patients Undergoing Pancreatectomy". This clinical trial tests the feasibility and how well a scheduled meditation intervention works to improve postoperative outcomes such as pain, anxiety, insomnia, stress and mobility for patients undergoing pancreatectomy. Many patients undergoing pancreatectomy surgery report clinically important ...
What is the current status of trial NCT07608458?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2026-06-25. Estimated completion is 2026-11-25.
What interventions are being tested in trial NCT07608458?
The interventions under investigation include: Survey Administration (OTHER), Online Mindfulness Meditation (BEHAVIORAL), Smartphone Application-based Intervention (BEHAVIORAL), Actigraphy (OTHER).
Who is sponsoring clinical trial NCT07608458?
This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07608458's enrollment target sits among peer trials
70 1103rd of 2000 higher than 868 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI